In general, NRP1 expression has been associated with cancer progression in multiple types of solid tumors (30), and diverse NRP1-targeting agents have been demonstrated to have tumor suppressing activity in mouse preclinical models (31, 32). Here, NRP1 is linked to neoplasm.